• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗后运动性肺动脉高压患者全身氧摄取受损:旧车装新引擎?

Impaired systemic oxygen extraction in treated exercise pulmonary hypertension: a new engine in an old car?

作者信息

Faria-Urbina Mariana, Oliveira Rudolf K F, Segrera Sergio A, Lawler Laurie, Waxman Aaron B, Systrom David M

机构信息

1 Division of Pulmonary and Critical Care Medicine, 1861 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

2 Heart & Vascular Center, Brigham and Women's Hospital, Boston, MA, USA.

出版信息

Pulm Circ. 2018 Jan-Mar;8(1):2045893218755325. doi: 10.1177/2045893218755325. Epub 2018 Jan 8.

DOI:10.1177/2045893218755325
PMID:29309261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5788103/
Abstract

Ambrisentan in 22 patients with pulmonary hypertension diagnosed during exercise (ePH) improved pulmonary hemodynamics; however, there was only a trend toward increased maximum oxygen uptake (VOmax) secondary to decreased maximum exercise systemic oxygen extraction (Ca-vO). We speculate that improved pulmonary hemodynamics at maximum exercise "unmasked" a pre-existing skeletal muscle abnormality.

摘要

在22例运动性肺动脉高压(ePH)患者中,安立生坦改善了肺血流动力学;然而,最大摄氧量(VOmax)仅呈上升趋势,这是由于最大运动时全身氧摄取(Ca-vO)降低所致。我们推测,最大运动时肺血流动力学的改善“掩盖”了先前存在的骨骼肌异常。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c6/5788103/5ceb71f313a7/10.1177_2045893218755325-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c6/5788103/5ceb71f313a7/10.1177_2045893218755325-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c6/5788103/5ceb71f313a7/10.1177_2045893218755325-fig1.jpg

相似文献

1
Impaired systemic oxygen extraction in treated exercise pulmonary hypertension: a new engine in an old car?治疗后运动性肺动脉高压患者全身氧摄取受损:旧车装新引擎?
Pulm Circ. 2018 Jan-Mar;8(1):2045893218755325. doi: 10.1177/2045893218755325. Epub 2018 Jan 8.
2
Open label study of ambrisentan in patients with exercise pulmonary hypertension.安立生坦治疗运动性肺动脉高压患者的开放标签研究。
Pulm Circ. 2017 Apr-Jun;7(2):531-538. doi: 10.1177/2045893217709024. Epub 2017 May 12.
3
Brief report: effect of ambrisentan treatment on exercise-induced pulmonary hypertension in systemic sclerosis: a prospective single-center, open-label pilot study.简短报告:安立生坦治疗系统性硬化症运动诱发性肺动脉高压的效果:一项前瞻性单中心、开放标签的试点研究。
Arthritis Rheum. 2012 Dec;64(12):4072-7. doi: 10.1002/art.34614.
4
Impaired systemic oxygen extraction at maximum exercise in pulmonary hypertension.肺动脉高压患者在最大运动时全身氧摄取受损。
Med Sci Sports Exerc. 2008 Jan;40(1):3-8. doi: 10.1249/mss.0b013e318159d1b8.
5
Unexplained exertional intolerance associated with impaired systemic oxygen extraction.与全身氧提取受损相关的不明原因的运动不耐受。
Eur J Appl Physiol. 2019 Oct;119(10):2375-2389. doi: 10.1007/s00421-019-04222-6. Epub 2019 Sep 6.
6
Dynamic right ventricular-pulmonary arterial uncoupling during maximum incremental exercise in exercise pulmonary hypertension and pulmonary arterial hypertension.运动性肺动脉高压和肺动脉高压患者在最大递增运动期间的动态右心室-肺动脉解偶联
Pulm Circ. 2019 Jul-Sep;9(3):2045894019862435. doi: 10.1177/2045894019862435.
7
Determinants of oxygen uptake. Implications for exercise testing.摄氧量的决定因素。对运动测试的意义。
Sports Med. 1997 Nov;24(5):308-20. doi: 10.2165/00007256-199724050-00003.
8
Is it possible to predict pulmonary arterial hypertension from an exercise test?
G Ital Cardiol. 1984;14 Suppl 1:56-60.
9
Measurement of the maximum oxygen uptake V̇o: V̇o is no longer acceptable.最大摄氧量V̇o的测量:V̇o不再适用。
J Appl Physiol (1985). 2017 Apr 1;122(4):997-1002. doi: 10.1152/japplphysiol.01063.2016. Epub 2017 Feb 2.
10
Ambrisentan for pulmonary arterial hypertension due to congenital heart disease.安贝生坦治疗先天性心脏病相关肺动脉高压。
Am J Cardiol. 2011 May 1;107(9):1381-5. doi: 10.1016/j.amjcard.2010.12.051. Epub 2011 Mar 2.

引用本文的文献

1
Exercise Pulmonary Hypertension and Beyond: Insights in Exercise Pathophysiology in Pulmonary Arterial Hypertension (PAH) from Invasive Cardiopulmonary Exercise Testing.运动性肺动脉高压及其他:有创心肺运动试验对肺动脉高压(PAH)运动病理生理学的见解
J Clin Med. 2025 Jan 26;14(3):804. doi: 10.3390/jcm14030804.
2
Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms.肺动脉高压运动不耐受:对中枢和外周病理生理机制的深入了解。
Eur Respir Rev. 2021 Apr 13;30(160). doi: 10.1183/16000617.0284-2020. Print 2021 Jun 30.
3
Vital capacity and valvular dysfunction could serve as non-invasive predictors to screen for exercise pulmonary hypertension in the elderly based on a new diagnostic score.

本文引用的文献

1
An official European Respiratory Society statement: pulmonary haemodynamics during exercise.欧洲呼吸学会官方声明:运动期间的肺血液动力学。
Eur Respir J. 2017 Nov 22;50(5). doi: 10.1183/13993003.00578-2017. Print 2017 Nov.
2
Open label study of ambrisentan in patients with exercise pulmonary hypertension.安立生坦治疗运动性肺动脉高压患者的开放标签研究。
Pulm Circ. 2017 Apr-Jun;7(2):531-538. doi: 10.1177/2045893217709024. Epub 2017 May 12.
3
Effects of bosentan on peripheral endothelial function in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.
基于一种新的诊断评分,肺活量和瓣膜功能障碍可作为无创预测指标,用于筛查老年人运动性肺动脉高压。
J Cardiovasc Thorac Res. 2021;13(1):68-78. doi: 10.34172/jcvtr.2021.05. Epub 2021 Jan 30.
4
Dynamic right ventricular-pulmonary arterial uncoupling during maximum incremental exercise in exercise pulmonary hypertension and pulmonary arterial hypertension.运动性肺动脉高压和肺动脉高压患者在最大递增运动期间的动态右心室-肺动脉解偶联
Pulm Circ. 2019 Jul-Sep;9(3):2045894019862435. doi: 10.1177/2045894019862435.
5
Treatment of exercise pulmonary hypertension improves pulmonary vascular distensibility.运动性肺动脉高压的治疗可改善肺血管扩张性。
Pulm Circ. 2018 Jul-Sep;8(3):2045894018787381. doi: 10.1177/2045894018787381. Epub 2018 Jun 19.
波生坦对肺动脉高压或慢性血栓栓塞性肺动脉高压患者外周血管内皮功能的影响。
Pulm Circ. 2016 Jun;6(2):168-73. doi: 10.1086/685715.
4
Ambrisentan for the treatment of adults with pulmonary arterial hypertension: a review.安立生坦治疗成人肺动脉高压的综述
Curr Med Res Opin. 2015;31(9):1793-807. doi: 10.1185/03007995.2015.1074890. Epub 2015 Aug 27.
5
Impaired Skeletal Muscle Oxygenation and Exercise Tolerance in Pulmonary Hypertension.肺动脉高压患者骨骼肌氧合受损与运动耐力下降
Med Sci Sports Exerc. 2015 Nov;47(11):2273-82. doi: 10.1249/MSS.0000000000000696.
6
Skeletal muscle proteomic signature and metabolic impairment in pulmonary hypertension.肺动脉高压中的骨骼肌蛋白质组学特征与代谢损伤
J Mol Med (Berl). 2015 May;93(5):573-84. doi: 10.1007/s00109-014-1244-0. Epub 2014 Dec 30.
7
Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension.血管生成受损和外周肌肉微循环丧失导致肺动脉高压运动耐量下降。
Am J Respir Crit Care Med. 2014 Aug 1;190(3):318-28. doi: 10.1164/rccm.201402-0383OC.
8
Anti-hypotensive treatment and endothelin blockade synergistically antagonize exercise fatigue in rats under simulated high altitude.抗低血压治疗与内皮素阻断协同拮抗模拟高原环境下大鼠的运动性疲劳。
PLoS One. 2014 Jun 24;9(6):e99309. doi: 10.1371/journal.pone.0099309. eCollection 2014.
9
Definitions and diagnosis of pulmonary hypertension.肺动脉高压的定义和诊断。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D42-50. doi: 10.1016/j.jacc.2013.10.032.
10
Skeletal muscle dysfunction in idiopathic pulmonary arterial hypertension.特发性肺动脉高压中的骨骼肌功能障碍。
Am J Respir Cell Mol Biol. 2014 Jan;50(1):74-86. doi: 10.1165/rcmb.2012-0506OC.